News - 23 Mar 2016
BNF 71 now published
The March 2016 edition of the British National Formulary, BNF 71 has now been published.
Some of the significant content updates for BNF 71 include:
- New safety information
- Updated advice for further measures to minimise risk of osteonecrosis of the jaw associated with use of Denosumab and intravenous bisphosphonates
- Updates to Immunisation schedule (Summer 2015)
- Addition of new preparations including Otezla® (apremilast), Kengrexal® (cangrelor), Velphoro® (sucroferric oxyhydroxide), and more
Access to the latest edition of the BNF is vital for healthcare professionals.